Arca
Skip to content
Tools
Tools

DNA-directed RNA polymerase

Complex in Clostridium difficile that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1
  • Genes: 4

Who is on it, and how far along

Every drug ChEMBL records acting on RPOA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Fidaxomicin

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        FidaxomicinApprovedMerck & Co. (MSD)Small moleculeInhibitorDNA-directed RNA polymerase inhibitor5

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 5 in all, from ClinicalTrials.gov.
        Vancomycin Taper to Prevent Recurrent Clostridioides DifficileFidaxomicinPhase 3RecruitingMcGill University Health Centre/Research Institute of the McGill University Health CentreJan 9, 2026
        STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile InfectionFidaxomicinNot applicableNot yet recruitingMedical University of WarsawAug 13, 2025
        Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard TherapyFidaxomicinEarly phase 1RecruitingMedical College of WisconsinMar 19, 2025
        Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel DiseaseFidaxomicinPhase 4Not yet recruitingBrigham and Women's HospitalJan 27, 2025
        Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First RecurrenceFidaxomicinPhase 3RecruitingBenoit GueryMar 4, 2022

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2363852, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.